Connect with us

Technology

Light AI Appoints John Tse as Vice President, Commercial Development

Published

on

Health Care Industry Veteran to Lead Company’s Product Commercialization

VANCOUVER, BC, April 9, 2025 /CNW/ – Light AI Inc. (“Light AI” or the “Company”) (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF) a global healthcare technology company focused on developing artificial intelligence (AI) health diagnostic and wellness solutions, today announced that it has appointed John Tse as Vice President, Commercial Development, effective immediately.

“I am thrilled to welcome John to our team. He brings extensive knowledge of our market and the commercialization of game changing initiatives,” said Peter Whitehead, CEO of Light AI. “With his deep connections to healthcare leaders in Canada and the USA, both in the industry and government sectors, John will be a tremendous asset to our organization.”

Recognized Health Care Industry Leader

Mr. Tse has thirty years of senior corporate management and executive leadership with London Drugs, inclusive as Vice President, Pharmacy and Cosmetics, where he was a key member of its executive team advanced the company to be one of the most recognized drug store chains in Canada and within the top 20 drug store chains in North America.

With advancements in healthcare and increasing complexity in treatment options, front line practitioners need assistance to deliver the right care to the right patients at the right time with a void in the healthcare technology space; Mr. Tse, a licensed pharmacist, embarked, in 2018, on an entrepreneurial path founding a bioinformatics/pharmacological healthcare company to identify and market innovative leading health care technology solutions.  

“I am excited to join Light AI at this important juncture as the Company transitions into commercialization of its leading AI health diagnostic and wellness solutions, says Mr. John Tse. “I have been monitoring Light AI’s research progress over the past several years and am very impressed with its AI powered medical condition diagnostic software application delivered via a mobile phone commencing with addressing Strep A infections. Light AI is well positioned to capitalize on a paradigm shift with its disruptive impactful product offering commencing with its consumer-oriented Wellness App in Q3 2025.”

Mr. Tse has been honored and nationally recognized for his outstanding contributions in supporting the development and excellence of pharmacy education at the university level; advancing the standards of healthcare delivery; providing an optimal environment for education and training for pharmacy staff to advance the standards of healthcare delivery; promoting pharmacy as a community resource in the provision of pharmacy services; and bringing the attention of government and industry partners as to the valuable contributions of community pharmacy. He is the recipient of the Canadian national Len Marks Pharmacy Advance Award in 2017 and the BC Pharmacy Association’s Lifetime Achievement Award which recognizes and honors pharmacists who have made significant, ongoing contributions to the pharmacy profession and its members in British Columbia, demonstrating a commitment to leadership and advancement.

Share Contractual Resale Restriction Commencement Date corrected to January 8, 2025

The Company also announced that the contractual resale restrictions of certain common shares issued upon the completion of the business combination completed on December 13, 2024 have been corrected from December 13, 2024 to the date upon which the common shares of the Company commenced trading on the Cboe CA Exchange, being January 8, 2025 with the related contractual resale restriction dates adjusted accordingly.

About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)

Light AI Inc. is a technology Company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A—to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective diagnostic tools designed to address critical healthcare challenges.

In pre-FDA validation studies, Light AI’s algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI’s technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI’s approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI’s vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

ON BEHALF OF THE COMPANY

“George Reznik”

George Reznik
Chief Financial Officer

Website: https://light.ai/
LinkedIn: LinkedIn/company/Light AI
X (Formerly Twitter): @lightaihealth

Forward-Looking Information:

This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the appointment of John Tse as Vice President, Business Development, the Company’s commercialization initiatives and other statements that contain words such as “believe,” “expect,” “project,” “should,” “seek,” “anticipate,” “will,” “intend,” “positioned,” “risk,” “plan,” “may,” “estimate” or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release.  For a list of the factors that may affect any of the Company’s forward-looking statements, please refer to the Company’s annual information form dated February 26, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at www.sedarplus.ca). Light AI disclaims any intention or obligation to update or revise any forward-looking information contained in this new release, whether as a result of new information, future events or otherwise, unless required by applicable law. The forward-looking information included in this news release is expressly qualified in its entirety by this cautionary statement.

SOURCE Light AI Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

VC Mastermind Launches: A Private Global Network and Podcast for Top-Tier Venture Capital Leaders

Published

on

By

SAN FRANCISCO, May 7, 2025 /PRNewswire/ — Today marks the official launch of VC Mastermind™, an exclusive, private network for VC Managing Partners. Designed for senior decision-makers at VC firms managing $50 million to $5 billion of institutional capital, VC Mastermind delivers premium insights, peer exchange, and operational best practices across all stages of a firm’s life cycle.

VC Mastermind Launches: A Private Global Network and Podcast for Top-Tier Venture Capital Leaders

Founded by Jacob Mullins – a 20-year veteran of the Silicon Valley startup tech and venture capital industry – VC Mastermind is built on first-hand experience. Mullins spent a decade as a startup founder (Exitround.com and others) and the past 10 years as a venture capitalist at Shasta Ventures and Village Global. His motivation was clear: “There’s no playbook for building a great venture firm. Most GPs are entrepreneurs themselves – scaling funds, managing teams, and trying to deliver returns in increasingly global and volatile markets.” After dozens of conversations with fellow GPs across cities like San Francisco, Tokyo, Dubai, and Mexico City, Mullins had the spark.

VC Mastermind fills a growing need for trusted, non-performative dialogue among GPs navigating a rapidly evolving industry. Through a members-only podcast and private events, the network delivers actionable strategies from Silicon Valley insiders and global venture leaders.

“GPs today are dealing with more operational complexity, tougher fundraising conditions, and rising LP expectations,” said Mullins. “VC Mastermind exists to serve those who are actively shaping the future of venture capital, with unfiltered insight on what’s really working inside the world’s best-performing firms.”

Membership includes:

A private weekly podcast featuring firm-building insights and guest interviews with leading GPs, COOs, and fund strategists

Monthly live virtual roundtables on topics like secondaries, succession planning, and new product development

Access to in-person events in cities including San Francisco, New York, Mexico City, London, Dubai and Tokyo and more

A trusted vendor directory and concierge support for firm operations and growth

Early podcast guests include leaders from Greenhill, DLA Piper, 500 Global, Dolby Family Ventures, Strut Consulting, and other experts in the venture capital industry across the U.S., Europe, Middle East, Latin America, and Asia.

Membership is by application only. Learn more and apply to join at www.vcmastermind.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/vc-mastermind-launches-a-private-global-network-and-podcast-for-top-tier-venture-capital-leaders-302448901.html

SOURCE VC Mastermind

Continue Reading

Technology

Base Molecular Resonance™ Technologies Receives $60.3 Billion IP Licensing Valuation Across 56 Global Use Cases

Published

on

By

Landmark Analysis from ipCapital Group Confirms Massive Licensing
Potential of BMRT’s Patented Technology Across Multiple Platforms

This valuation represents one of the largest IP licensing valuations ever assigned to a  pre-revenue technology firm. 

“Having assessed and evaluated the BMRT technology, it is clear to me that I have never seen anything quite like it. Indeed, breakthrough technologies which can support every aspect of society are few and far between, leading to multinational success and Nobel Prize-worthy impact.” – Professor Philippe B. Wilson, PhD, Lead Scientist, Landmark Validation Study  

These 56 use cases represent a portion of the broader potential applications, and the valuation is limited to the US and EU markets, excluding the additional impact and value globally.

STUART, Fla., May 7, 2025 /PRNewswire/ — Base Molecular Resonance™ Technologies (BMRT), a pioneer in quantum physics and subatomic-level detection technology, today announced that ipCapital Group has issued a comprehensive licensing valuation. The analysis estimates BMRT’s intellectual property (IP) portfolio at $60.3 billion across the United States and European Union, covering 56 distinct use cases across key global industries. BMRT currently maintains 19 patent assets, with another 200 anticipated in the next 24 months.

Its potential to save lives, safeguard national interests, strengthen security infrastructure, and redefine entire industries underscores its status as a transformative breakthrough in modern science and technology

IP Capital Group (ipCG), founded by John Cronin, the former top patent holder at IBM and creator of its “patent factory,” is a leading IP and innovation consulting firm. With over 2,000 successful engagements, including work with more than 20% of the Fortune 500, ipCG is recognized for its deep expertise in valuing high-impact technologies.

Robert “Bo” Short, BMRT Co-Founder & CEO said, “Our technology was designed to solve complex problems across multiple domains. This valuation from ipCG affirms what we have always known, that Base Molecular Resonance™ is not only a scientific breakthrough in quantum physics, but also one of the most commercially valuable technologies in the world. Its potential to save lives, safeguard national interests, strengthen security infrastructure, and redefine entire industries underscores its status as a transformative breakthrough in modern science and technology.”

The independent valuation analysis highlights the broad commercial potential of BMR™ technology across key sectors. It demonstrates the scalable impact of the technology across mission-critical applications. While not limited to these strategic domains, the list includes:

Medical & HealthcareSecurity & ForensicsIndustrial & ManufacturingEnvironmental Monitoring & SafetyAgriculture & Food SafetySmart Cities & InfrastructureConsumer & RetailMilitary, Aerospace, & Space

ipCG applied a proxy ratio approach to estimate BMRT’s IP value across 56 use cases, leveraging prior income-based valuations in the Cancer and Security verticals. By deriving average patent-to-market value ratios (3.46% U.S., 3.26% EU) from detailed financial models, ipCG applied these as scaling factors to 2025 projected market sizes. This enabled consistent, risk-adjusted licensing analysis across diverse industries, grounded in previously validated methodologies.

“This valuation reflects just one dimension of BMR™ technology, our intellectual property licensing potential,” said Lee Duke, BMRT Co-Founder & President. “It does not capture the full breadth of our commercialization strategy, which includes direct deployment, strategic government partnerships, and targeted sector integrations. We are only beginning to unlock the broader impact this technology will have across global markets. While the revenue potential is immense, the true value lies in the global impact and life saving outcomes this technology enables.”

BMRT’s technology was independently validated by the Centre for Applied Innovation at York St John University in York, England. In a rigorous blind and double blind study, the technology demonstrated 100% accuracy with no false positives or false negatives in detecting cancer, gunpowder, illicit drugs, and high threat materials. These unprecedented results were consistent at both close range and long distance, including through walls and buildings. In the case of high threat materials, detection was successfully achieved from distances of hundreds of miles.

Professor Philippe B. Wilson, PhD, Associate Pro-Vice Chancellor for Innovation and Knowledge Exchange and Director of the Centre for Applied Innovation at York St John University, stated, “Having assessed and evaluated the BMRT technology, it is clear to me that I have never seen anything quite like it. Indeed, breakthrough technologies which can support every aspect of society are few and far between, leading to multinational success and Nobel Prize-worthy impact.”

For more information, visit www.BMRT.io 

Investment Inquiries 
Robert “Bo “Short
Co-Founder & CEO
bo@BMRT.io 

Media Contact 
Bryan Adams
info@bmrt.io 
800.522.4718 Ext. 1

About Base Molecular Resonance™ Technologies (BMRT) 
BMRT has discovered a new area of quantum physics that utilizes resonant frequencies to detect particle interactions at subatomic levels. This technology, called Base Molecular Resonance™ (BMR™), can detect any compound or biological substance, including every element on the periodic table, and up to 200 cancers and other diseases. With over 20 years of prototyping and testing proving its unmatched detection capabilities, BMR™ has the potential to save millions of lives by pinpointing weapons, explosives, and other physical threats both up close and at great distances, and detecting cancers and other diseases long before they present clinical symptoms. The non-invasive, harmless, and instant scan has broad implications in cancer diagnostics, public safety, law enforcement, security, and military services.

View original content to download multimedia:https://www.prnewswire.com/news-releases/base-molecular-resonance-technologies-receives-60-3-billion-ip-licensing-valuation-across-56-global-use-cases-302448910.html

SOURCE Base Molecular Resonance Technologies, LLC

Continue Reading

Technology

Less Friction, More Joy: How viaim RecDot Turns Work Wins into Brighter Days

Published

on

By

Smart, effortless, and always in sync — RecDot helps users stay productive without missing life’s little moments

LOS ANGELES, May 7, 2025 /CNW/ — In a world where back-to-back meetings and endless messages are the norm, AI hardware brand viaim believes productivity tools shouldn’t just reduce stress, they should bring a bit more ease into our day. RecDot, its AI-powered earbuds help users work smarter and feel better doing it. 

Whether it’s navigating a multilingual call, adjusting supply chains in real time, or capturing key moments from a podcast, viaim RecDot empowers users to turn hectic interactions into clear, productive wins.

For freelance translator Emily Chung, clarity is not a ‘nice to have’, but it is essential to her work. Based in Los Angeles, she spends her days jumping between Japanese and English meetings for clients in the tech industry. Before RecDot, she often had to replay hours of recordings to double-check technical terms. Now, real-time English subtitles flag tricky terms like 仕様書.” When a client mistakenly translates it as Specification Book,” Emily spots it immediately and confirms the correct usage as Technical Specifications” before confusion spreads. Later, she uses RecDots summary feature to auto-generate a glossary and drop it straight into the project folder.

RecDot feels like my second set of eyes,” she says. Its cut my delivery time in half – and my headaches, too.”With real-time transcription and instant glossary creation, RecDot helps language professionals stay accurate and efficient without the need to replay a single minute.

Across the country in New York, David Fleming, the founder of a cross-border e-commerce startup, faces a different kind of pressure. With teams in Mexico, China, and the U.S., his calendar is a constant negotiation of time zones and to-do lists. During one supplier call, an urgent logistics email pulls his focus just as a vendor in Shenzhen announces a shipping delay. But RecDots live subtitle stream displays the message Delivery postponed to May 20th” across his screen. He adjusts the logistics chain in real time and adds a follow-up note with one tap.

“RecDot is like my meeting bodyguard, even when I’m distracted. It never misses a beat.” For fast-paced professionals like David, RecDot turns interruptions into momentum, keeping teams responsive, confident, and moving forward.

And for Lina Tripp, a university student and part-time tech blogger in Toronto, RecDot has quietly changed the way she learns. She uses the earbuds to record and transcribe podcasts and lectures, watching as chapter-marked captions unfold live on her screen. After class, she exports a clean set of notes, organized and searchable. When she recently had to analyze a Spanish-language industry panel for her blog, RecDot translated it into English subtitles on the fly.

“It’s like doubling my study time without adding hours. My GPA jumped from 3.2 to 3.7 – my professor thought Id hired a tutor.” Whether it’s content capture, language support, or smarter study habits, RecDot helps turn small wins into lasting results. From podcast to paper, RecDot supports smarter study habits with searchable, structured notes, and built-in translation.

The stories differ, but the results echo: less friction, more focus, and a little more space to enjoy the ride. These aren’t just technical features — they’re design choices rooted in viaim’s belief that “real intelligence” supports real life, not just data points. As viaims Chief Product Officer Alex Chen puts it, A smile isnt a marketing message, it’s what happens when a product works. RecDot reflects our belief that real intelligence means designing for real-life moments, not just metrics.”

We may not always notice it, but the best kind of tech is the kind that quietly shifts your day for the better, helping you stay productive, focused, and maybe even smile a little more along the way.

Ready for less friction and more wins? Explore viaim at  https://store.viaim.ai.

About viaim

viaim is dedicated to “Real Intelligence,” enhancing workplace efficiency and creativity through innovative AI products. Its flagship offerings include viaim RecDot earbuds with multilingual transcription and noise reduction capabilities, and viaim NoteKit, an intelligent meeting tool for capturing summaries and to-do lists.

View original content to download multimedia:https://www.prnewswire.com/news-releases/less-friction-more-joy-how-viaim-recdot-turns-work-wins-into-brighter-days-302448586.html

SOURCE VIAIM

Continue Reading

Trending